HHLR ADVISORS, LTD.
Known title: 10% OwnerCIK: 0001762304
Associated companies
Transaction History
| ONC | ▼ Sell | Open Market | 17,842,500 | $3568.5M | 12/2/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 273,728 | $56.9M | 6/14/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 611,000 | $129.2M | 6/13/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 313,400 | $40.3M | 6/13/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 281,400 | $36.8M | 6/12/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 968,812 | $207.2M | 6/12/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 213,700 | $27.9M | 6/9/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 328,952 | $71.4M | 6/9/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 1,163,825 | $253.9M | 6/8/2023 | View on chart |
| ONC | ▼ Sell | Other | 7,800 | $0 | 8/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List
BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.
BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List. BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.